Securities at amortized cost (AC) (Tables)

12 Months Ended

Dec. 31, 2025

Financial Assets At Amortized Cost - Securities [Abstract]

Schedule of Amortized Cost of Financial Assets at Amortized Cost


			12/31/2025						12/31/2024
			Gross book value						Gross book value
Government securities			126,693						158,680
Brazil			105,678						111,824
Latin America			5,974						21,730
Abroad			15,041						25,126
Corporate securities			193,458						168,827
Rural product note			69,778						60,358
Bank deposit certificates			63						50
Real estate receivables certificates			4,209						5,827
Debentures			79,168						77,344
Eurobonds and other			11,690						1,102
Financial bills			379						212
Promissory and commercial notes			21,359						16,312
Other			6,812						7,622
Investment funds			9,814						-
Total			329,965						327,507
Expected credit loss			(2,492)						(3,655)
Amortized cost			327,473						323,852

Securities at amortized cost, by maturity:


			12/31/2025									12/31/2024
			Gross book value			Amortized cost						Gross book value			Amortized cost
Current			74,248			73,583						90,213			88,582
Up to one year			74,248			73,583						90,213			88,582
Non-current			255,717			253,890						237,294			235,270
From one to five years			189,524			187,986						165,759			164,332
From five to ten years			52,987			52,748						60,289			59,694
After ten years			13,206			13,156						11,246			11,244
Total			329,965			327,473						327,507			323,852

Schedule of Reconciliation of Expected Loss

Reconciliation of expected credit loss for securities at amortized cost, segregated by stages:


Stage 1			Balance at 12/31/2024			Transfer to Stage 2			Transfer to Stage 3			Cure from Stage 2			Cure from Stage 3			(Increase) / Reversal			Write-off			Balance at 12/31/2025
Government securities			(28)			-			-			-			-			20			-			(8)
Corporate securities			(296)			(10)			46			(39)			(1)			62			-			(238)
Total			(324)			(10)			46			(39)			(1)			82			-			(246)


Stage 2			Balance at 12/31/2024			Cure to Stage 1			Transfer to Stage 3			Transfer from Stage 1			Cure from Stage 3			(Increase) / Reversal			Write-off			Balance at 12/31/2025
Corporate securities			(125)			39			175			10			(18)			(842)			-			(761)
Total			(125)			39			175			10			(18)			(842)			-			(761)


Stage 3			Balance at 12/31/2024			Cure to Stage 1			Cure to Stage 2			Transfer from Stage 1			Transfer from Stage 2			(Increase) / Reversal			Write-off			Balance at 12/31/2025
Corporate securities			(3,206)			1			18			(46)			(175)			1,860			63			(1,485)
Total			(3,206)			1			18			(46)			(175)			1,860			63			(1,485)


Stage 1			Balance at 12/31/2023			Transfer to Stage 2			Transfer to Stage 3			Cure from Stage 2			Cure from Stage 3			(Increase) / Reversal			Write-off			Balance at 12/31/2024
Government securities			(36)			-			-			-			-			8			-			(28)
Corporate securities			(147)			449			149			(166)			(88)			(493)			-			(296)
Total			(183)			449			149			(166)			(88)			(485)			-			(324)


Stage 2			Balance at 12/31/2023			Cure to Stage 1			Transfer to Stage 3			Transfer from Stage 1			Cure from Stage 3			(Increase) / Reversal			Write-off			Balance at 12/31/2024
Corporate securities			(122)			166			416			(449)			(13)			(123)			-			(125)
Total			(122)			166			416			(449)			(13)			(123)			-			(125)


Stage 3			Balance at 12/31/2023			Cure to Stage 1			Cure to Stage 2			Transfer from Stage 1			Transfer from Stage 2			(Increase) / Reversal			Write-off			Balance at 12/31/2024
Corporate securities			(549)			88			13			(149)			(416)			(2,193)			-			(3,206)
Total			(549)			88			13			(149)			(416)			(2,193)			-			(3,206)